News

The oral TYK2 inhibitor demonstrates significant potential for treating active psoriatic arthritis in adults. Bristol Myers Squibb (BMS) has announced...

Eli Lilly Korea has introduced Ebglyss, a new biologic therapy designed to treat moderate-to-severe atopic dermatitis. The treatment, which comes...

Psoriasis, a systemic condition often viewed solely from a dermatological lens, is associated with various comorbidities, including metabolic syndrome, heart...

Biocon's stock surged by 8.5% on Tuesday, January 7, reaching ₹389 per share, a level not seen since mid-September. The...

L'Oréal Groupe has launched a new device designed to revolutionize skin care by providing consumers with a personalized analysis in...

Infants with atopic dermatitis (AD) are at an increased risk for developing a sequence of allergic conditions, a phenomenon known...

Johnson & Johnson (J&J) has announced a new licensing agreement with Kaken Pharmaceutical to expand its pipeline for treating atopic...

A breakthrough in treating inflammatory skin conditions like eczema could be on the horizon, thanks to new research from American...

Researchers have identified a key predictor for the development of asthma in young children: the presence of eosinophilic inflammation in...

A groundbreaking skincare solution promises to reduce facial redness instantly and over time, targeting conditions like rosacea, eczema, and irritated...